Marcio Souza
Marcio Souza's purchase track record
How the stock did after each of Marcio Souza's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/27/2023 | PRAX | $11K | +38.3% | +41.7% | +9.0% |
| 3/23/2023 | PRAX | $60K | +34.7% | +74.5% | +9.7% |
| 8/25/2022 | SYRE | $50K | +137.1% | -15.9% | -4.5% |
| 6/8/2022 | PRAX | $50K | +76.1% | +14.4% | -4.4% |
| 8/18/2021 | PRAX | $151K | +17.2% | -17.5% | +1.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Spyre Therapeutics Launches $350M Public Offering, Stock Drops. Spyre Therapeutics has priced a $350 million public offering of common stock, which led to a decline in the share price on the launch day. The company also announced inducement awards to support its growth. Analysts from JP Morgan and BTIG have begun coverage, citing a target price around $110 to $121. The offering and analyst interest may influence the stock’s short‑term trajectory.
Transaction History
| PRAX | ▼ Sell | Gift | 20,521 | $0 | 7/8/2026 | View on chart |
| PRAX | ▼ Sell | Gift | 2,600 | $0 | 7/8/2026 | View on chart |
| PRAX | ▲ Buy | Grant | 126 | $21K | 5/14/2026 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 4,252 | $1.2M | 1/10/2026 | View on chart |
| PRAX | ▲ Buy | Grant | 27,640 | $0 | 1/8/2026 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 405 | $119K | 1/7/2026 | View on chart |
| PRAX | ▼ Sell | Gift | 400 | $0 | 12/30/2025 | View on chart |
| PRAX | ▲ Buy | Grant | 348 | $11K | 5/14/2025 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 401 | $34K | 2/12/2025 | View on chart |
| PRAX | ▲ Buy | Grant | 37,500 | $0 | 1/10/2025 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 434 | $34K | 1/7/2025 | View on chart |
| PRAX | ▲ Buy | Grant | 1,718 | $21K | 5/14/2024 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 271 | $12K | 2/12/2024 | View on chart |
| PRAX | ▼ Sell | Tax Withholding | 418 | $11K | 1/7/2024 | View on chart |
| PRAX | ▲ Buy | Open Market | 10,000 | $11K | 6/27/2023 | View on chart |
| PRAX | ▲ Buy | Grant | 11,687 | $10K | 5/12/2023 | View on chart |
| PRAX | ▲ Buy | Open Market | 35,000 | $30K | 3/23/2023 | View on chart |
| PRAX | ▲ Buy | Open Market | 35,002 | $30K | 3/23/2023 | View on chart |
| PRAX | ▲ Buy | Grant | 2,115 | $4K | 11/14/2022 | View on chart |
| SYRE | ▲ Buy | Open Market | 90,000 | $50K | 8/25/2022 | View on chart |
| PRAX | ▲ Buy | Open Market | 27,000 | $50K | 6/8/2022 | View on chart |
| PRAX | ▲ Buy | Grant | 1,392 | $12K | 5/13/2022 | View on chart |
| PRAX | ▲ Buy | Grant | 74,000 | $0 | 1/7/2022 | View on chart |
| PRAX | ▲ Buy | Open Market | 9,542 | $151K | 8/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Praxis Precision Announces Inducement Grants Under Nasdaq Rule
Praxis Precision Medicines disclosed that it will issue inducement grants under Nasdaq Listing Rule 5635(c)(4). This move is a compliance measure aimed at meeting Nasdaq’s shareholder requirements and may affect the company’s share structure. The announcement is a routine regulatory update rather than a new product or earnings event.
Praxis Precision Announces Inducement Grants Under Nasdaq Rule. Praxis Precision Medicines disclosed that it will issue inducement grants under Nasdaq Listing Rule 5635(c)(4). This move is a compliance measure aimed at meeting Nasdaq’s shareholder requirements and may affect the company’s share structure. The announcement is a routine regulatory update rather than a new product or earnings event.